What is Denali Therapeutics Inc.'s restricted cash?

Denali Therapeutics Inc. (DNLI) reported restricted cash of $3.1M in Q1 2026.

How has Denali Therapeutics Inc.'s restricted cash changed year-over-year?

Denali Therapeutics Inc.'s restricted cash decreased by 0.0% year-over-year, from $3.1M to $3.1M.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Denali Therapeutics Inc. DNLI Restricted Cash

Restricted Cash at other companies

Acadia PharmaceuticalsACAD

$7.85M-10.5%

Beam TherapeuticsBEAM

$6.69M+1.3%

ALN

Alnylam PharmaceuticalsALNY

$1.64M-36.8%

BioCryst PharmaceuticalsBCRX

$854K+193%

Regeneron PharmaceuticalsREGN

——

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue-—

Operating income-$137.4M+5.6%

Net income-$128.4M+3.4%

EPS (diluted)-$0.69+11.5%

Balance sheet

See full

Cash & equivalents$390.7M+551%

Total debt$40.0M-22.3%

Total equity$926.1M-17.5%

Total assets$1.3B-0.4%

Cash flow

See full

Operating cash flow-$131.2M+0.2%

CapEx$2.5M-51.4%

Free cash flow-$133.7M+2.1%

Valuation

See full

Market cap$3.93B+54.2%

Profitability

See full

Operating margin-37,938%-37,986pp

Net margin-33,121.9%-33,159pp

FCF margin-31,736.3%-31,830pp

Returns & leverage

See full

Return on equity-49.6%+34.2pp

Debt / equity0×0.0×

Current ratio9.3×-0.3×

Where this comes from

Reported directly by Denali Therapeutics Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalentsNoncurrent.

The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Denali Therapeutics Inc.'s restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Denali Therapeutics Inc.'s restricted cash?: Denali Therapeutics Inc. (DNLI) reported restricted cash of $3.1M in Q1 2026.
How has Denali Therapeutics Inc.'s restricted cash changed year-over-year?: Denali Therapeutics Inc.'s restricted cash decreased by 0.0% year-over-year, from $3.1M to $3.1M.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.